Pecuniary compensation increases participation in screening for colorectal cancer

Health Economics

Volumn 18, Issue 3, 2009, Pages 337-354

  Aas, Eline ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Binary probit; Compensation; Cost; Health screening programme; Willingness to pay

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COLORECTAL CANCER; COMPENSATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; EDUCATION; FEMALE; GENETIC PREDISPOSITION; HEALTH SERVICE; HEALTH STATUS; HUMAN; INCOME; INDIVIDUALITY; MAJOR CLINICAL STUDY; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROBABILITY; TRAVEL; AGE; COLORECTAL TUMOR; DECISION MAKING; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REIMBURSEMENT; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; UTILIZATION REVIEW;

AGE FACTORS; COLORECTAL NEOPLASMS; DECISION MAKING; FEMALE; FINANCING, PERSONAL; GENETIC PREDISPOSITION TO DISEASE; HEALTH CARE COSTS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMIC; MULTIVARIATE ANALYSIS; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; PROBABILITY; PSYCHOMETRICS; REIMBURSEMENT MECHANISMS; SOCIOECONOMIC FACTORS;

EID: 65349166316     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1371     Document Type: Article

References (43)

1. Aas E. 2004. Participation in screening for colorectal cancer. Økonomisk Forum 7: 34-44.
2. Aas E. 2008. Screening from a Health Economics perspective. Dissertation, ISSN 1501-3991. Faculty of Social Science, University of Oslo.
3. Achat H, McIntyre P, Burgess M. 1999. Health care incentives in immunization. Australia/New Zealand Journal of Public Health 23(3): 285-288.
4. Atkin WS, Whynes DK. 2000. Improving the cost-effectiveness of colorectal cancer screening. Journal of the National Cancer Institute 7: 513-514.
5. Ben-Akiva, Lerman. 1985. Discrete Choice Analysis: Theory and Application to Travel Demand. MIT Press Series in Transportation Studies, vol. 9, MIT Press: Cambridge, MA.
6. Berchi C, Dupuis JM, Launoy G. 2006. The reason of general practitioners for promoting colorectal cancer mass screening in France. European Journal of Health Economics 7: 91-98.
7. Bretthauer M, Gondal G, Larsen IK, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH, Hoff G. 2002. Design, organization and management of a controlled population screening study for detection of colorectal Neoplasia. Scandinavian Journal of Gastroenterology 5: 569-573.
8. Buekens P, Kotelchuck M, Blondel B, Kristensen FB, Chen JH, Masuy-Stroobant G. 1993. A comparison of prenatal care use in the United States and Europe. American Journal of Public Health 83: 31-36.
9. Byrne MM, Thompson P. 2001. Screening and preventable illness. Journal of Health Economics 20: 1077-1088.
10. Cole SR, Young GP, Byrne D, Guy JR, Morcom J. 2002. Participation in screening for colorectal cancer based on a faecal occult blood test in improved endorsement by the primary care practitioner. Journal of Medical Screening 9: 147-152.
11. Davis K, Bialek R, Parkinson M, Smith J, Vellozzi C. 1990. Reimbursement for preventive services: can we construct an equitable system? Journal of General International Medicine 5(5 suppl): S93-S98.
12. FitzGerald JM, Patric DM, Strathdee S, Rekart M, Elwood RK, Schecter MT, Montaner J, O'Shaughnessy M, and the Vancouver Injection Drug Use Study Group. 1999. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. International Journal of Tuberculosis Lung Disease 3(2): 153-155.
13. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. 2000. Cost-effectiveness of screening for colorectal cancer in the general population. Journal of the American Medical Association 15: 1954-1961.
14. Grossman M. 1972. On the concept of health capital and the demand for health. Journal of Political Economy 80: 223-255.
15. Guiffrida A, Gravelle H. 1998. Paying patients to comply: an economic analysis. Health Economics 7: 569-579.
16. Guiffrida A, Torgerson DJ. 1997. Should we pay the patient? Review of financial incentives to enhance patient compliance. British Medical Journal 315: 703-707.
17. Gyrd-Hansen D, Søgaard J. 2001. Analysing public preferences for cancer screening programmes. Health Economics 10: 617-634.
18. Gyrd-Hansen D, Søgaard J, Kronborg O. 1998. Colorectal cancer screening: efficiency and effectiveness. Health Economics 7: 9-20.
19. Harewood GC, Wiersema MJ, Melton LJ. 2002. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. The American Journal of Gastroenterology 12: 3186-3194.
20. Hey K, Perera R. 2007. Competitions and incentives for smoking cessation (Review). The Cochrane Library 2007 Issue 4.
21. Hoel M. 2007. What should the (public) insurance cover? Journal of Health Economics 26: 252-262.
22. Hoff G, Vatn MH, Gjone E, Larsen S, Sauar J. 1985. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scandinavian Journal of Gastroenterology 20: 351-355.
23. Leodolter I. 1978. Short report: the Mother-Child Health Passport: Austria's successful weapon against infant mortality. Preventive Medicine 7: 561-563.
24. Leshno M, Halpern Z, Arber N. 2003. Cost-effectiveness of colorectal cancer screening in the average risk population. Health Care Management Science 6: 165-174.
25. Lieberman D. 1995. Cost-effectiveness model for colon cancer screening. Gastroenterology 109: 1781-1790.
26. McCaffery K, Wardle J, Nadel M, Atkin W. 2002. Socioeconomic variation in participation in colorectal cancer screening. Journal of Medical Screening 9: 104-108.
27. McGrath JS, Ponich TP, Gregor JC. 2002. Screening for colorectal cancer: the cost to find an advanced adenoma. The American Journal of Gastroenterology 11: 2902-2907.
28. Newhouse JP. 2006. Reconsidering the moral hazard-risk avoidance trade-off. Journal of Health Economics 25: 1005-1014.
29. NORCCAP - Norwegian Colorectal Cancer Prevention. 2001. Samlede årsrapporter for perioden 1998-2001 (Annual report). NORCCAP.
30. Pauly MV, Held PJ. 1990. Benign moral hazard and the cost-effectiveness analysis of insurance coverage. Journal of Health Economics 9: 447-461.
31. Petersen GM. 2002. Barriers to preventive intervention. Gastroenterology of Clinics of North America 31: 1061-1068.
32. Seip K, Strand J. 1992. Willingness to pay for environmental goods in Norway: a contingent valuation study with real payment. Environmental and Resource Economics 2: 91-106.
33. Sonnenberg A, Delcò F, Inadomi JM. 2000. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Annals of Internal Medicine 8: 573-584.
34. Statistics Norway. 2002. The Postal Questionnaire. Statistics in Norway.
35. Strand J. 2003. Public-good valuation and intrafamily allocation. HERO-Report 20.
36. Sutton S, Wardle J, Taylor T, McCaffery K, Williamson S, Edwards R, Cuzick J, Hart A, Northover J, Atkin W. 2000. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. Journal of Medical Screening 7: 99-104.
37. The Norwegian Ministry of Finance. 2005. Veileder i samfunnsokonomiske analyser (Guidance in Economic Evaluation). The Norwegian Ministry of Finance. (Available from: http://odin.dep.no/ filarkiv/258190/Veileder_samf.ok.analyser_2005.pdf.)
38. The Norwegian Ministry of Finance. 2006. St.prop 1 (2006-2007), for budsjettåret 2007. Skatte-, avgifts- og tollvedtak. The Norwegian Ministry of Finance. (Available from: http:/ /www.regjeringen.no/nb/dep/fin/dok/regpubl/stprp/20062007 /Stprp-nr-1-2006-2007-3/2.html?id5298033.)
39. TSP. 1999. TSP User's Guide and Reference Manual Version 4.5. TSP International.
40. Vernon SW. 1997. Participation in colorectal cancer screening: a review. Journal of the National Cancer Institute 19: 1406-1422.
41. Walker A, Whynes DK. 1991. Participation and screening programmes for colorectal cancer: more would be better? Journal of Health Economics 10: 207-225.
42. Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, Atkin W. 2003. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychology 22: 99-105.
43. Whynes DK, Frew EJ, Edwards R, Atkin WS. 2003. Cost of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. International Journal of Technology Assessment in Health Care 2: 384-395.